USD in millions, except per-share amounts and margins. The percent under a figure is the change from the same quarter a year earlier.
| Line |
Q4 FY2026
Mar 31, 2026
|
Q3 FY2026
Dec 31, 2025
|
Q2 FY2026
Sep 30, 2025
|
Q1 FY2026
Jun 30, 2025
|
Q4 FY2025
Mar 31, 2025
|
Q3 FY2025
Dec 31, 2024
|
Q2 FY2025
Sep 30, 2024
|
Q1 FY2024
Jun 30, 2024
|
|---|---|---|---|---|---|---|---|---|
| Weighted average shares, basic |
385
+149.2%
|
346
+213.3%
|
274
+215.6%
|
188
|
154
|
110
|
87
|
79
+44.0%
|
| Weighted average shares, diluted |
385
+149.2%
|
346
+213.3%
|
274
+215.6%
|
188
|
154
|
110
|
87
|
79
+44.0%
|
How these figures are calculated
Quarterly columns are single-quarter amounts. When a 10-Q reports only a year-to-date total, as cash flow statements do, the quarter is that total minus the previous quarter's year-to-date total. The fourth quarter is the annual report's full year minus the first nine months. A column marked YTD is a year-to-date total, shown when the earlier report needed for the single quarter is missing. USD in millions, except per-share amounts and margins. Weighted average shares are in millions. Interest expense and finance costs are positive costs. A negative amount on a gain (loss) or income (expense) line is a loss or an expense. EBITDA is operating income plus depreciation and amortization. Interest coverage is operating income divided by interest expense. More on our methodology.
New to this? Read How to Read an Income Statement, With a Real Example.
Company profile
- Industry
- Medicinal Chemicals & Botanical Products (SIC 2833)
- Listed as
- CGC (Nasdaq)
- Fiscal year ends
- March 31
- Incorporated in
- Canada (Federal Level)
- Headquarters
- Smith Falls, Ontario, Canada
- SEC filer status
- Accelerated filer
- SEC CIK
- 1737927
Other Medicinal Chemicals & Botanical Products companies
- Definium Therapeutics, Inc. DFTX
- Regencell Bioscience Holdings Ltd RGC
- Curaleaf Holdings, Inc. CURLF
- Trulieve Cannabis Corp. TRLV
- Cronos Group Inc. CRON
- TFA Therapeutics, Inc. RAJAF
- Tilray Brands, Inc. TLRY
- SNDL Inc. SNDL
Source: SEC EDGAR filings. This is company-reported data, not investment advice.